Log In
Print
BCIQ
Print
Print this Print this
 

ALX-0761

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionTrivalent Nanobody against IL-17A and IL-17F
Molecular Target Interleukin-17A (IL-17A) ; Interleukin-17F (IL-17F)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today